| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.17▲ | 1.19▼ | 1.19▼ | 1.22▼ | 1.17▼ |
| MA10 | 1.18▼ | 1.20▼ | 1.22▼ | 1.17▲ | 1.16▲ |
| MA20 | 1.19▼ | 1.23▼ | 1.27▼ | 1.20▼ | 1.38▼ |
| MA50 | 1.19▼ | 1.26▼ | 1.20▼ | 1.20▼ | 2.03▼ |
| MA100 | 1.24▼ | 1.19▼ | 1.18▼ | 1.44▼ | 4.45▼ |
| MA200 | 1.28▼ | 1.19▼ | 1.18▼ | 2.05▼ | 91.97▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.005▼ | -0.018▼ | 0.011▲ | 0.033▲ |
| RSI | 32.230▼ | 33.644▼ | 36.804▼ | 48.244▼ | 38.793▼ |
| STOCH | 16.667▼ | 13.421▼ | 4.631▼ | 54.285 | 22.524 |
| WILL %R | -66.667 | -91.667▼ | -95.000▼ | -71.014 | -80.488▼ |
| CCI | -86.667 | -139.103▼ | -92.962 | 29.146 | -27.245 |
|
Thursday, May 28, 2026 04:10 AM
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company built on artificial intelligence (“AI”) to develop transformative medicines in neuroscience, today announced the presentation of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 29/05/26 | 1.28 | 1.28 | 1.16 | 1.17 | 1,042,817 |
| 28/05/26 | 1.31 | 1.365 | 1.26 | 1.26 | 1,442,925 |
| 27/05/26 | 1.22 | 1.415 | 1.22 | 1.31 | 1,733,789 |
| 26/05/26 | 1.13 | 1.235 | 1.13 | 1.22 | 501,881 |
| 22/05/26 | 1.15 | 1.175 | 1.13 | 1.13 | 348,912 |
| 21/05/26 | 1.09 | 1.14 | 1.08 | 1.14 | 380,100 |
| 20/05/26 | 1.09 | 1.105 | 1.07 | 1.09 | 485,549 |
| 19/05/26 | 1.15 | 1.15 | 1.08 | 1.08 | 498,215 |
| 18/05/26 | 1.16 | 1.19 | 1.12 | 1.13 | 641,681 |
| 15/05/26 | 1.17 | 1.21 | 1.14 | 1.14 | 573,942 |
|
|
||||
|
|
||||
|
|